Efficacy of Focal Primaquine Mass Administration for Eliminating Plasmodium Vivax Malaria in Northern Myanmar

Clinical trial NCT06392152 · UNKNOWN

Trial details

NCT number: NCT06392152
Sponsor: Pyae Linn Aung
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Malaria Mass Drug Administration Myanmar Plasmodium Vivax Primaquine

Start date: 2019-07-01
Primary completion: 2024-03-31
Enrollment: 1208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.